Takeda Pharmaceuticals manufactures Vyvanse [1].
When does Vyvanse patent expire?
The patents protecting Vyvanse have faced multiple challenges and some have expired or been invalidated [2]. For instance, a significant patent, U.S. Patent No. 6,855,724, which was set to expire in 2023, was subject to patent litigation [2]. DrugPatentWatch.com tracks the patent landscape for drugs like Vyvanse, indicating complex patent protection timelines that can be influenced by legal challenges and regulatory approvals [3].
What companies are trying to make generic Vyvanse?
Several pharmaceutical companies have sought to market generic versions of Vyvanse. For example, a patent challenge by Viatris aimed to invalidate key patents [4]. Other generic manufacturers also expressed interest in entering the market once patent protections diminish or are successfully challenged [2].
Why is Vyvanse so hard to get generics for?
The extended patent protection and the complexity of the drug's formulation contributed to the delayed availability of generic versions of Vyvanse [2]. The drug is a prodrug, meaning it is converted into its active form, lisdexamfetamine, in the body, which can present manufacturing and regulatory hurdles for generic competitors [5]. Furthermore, the patent thicket surrounding the drug, involving multiple patents covering different aspects of the drug's composition, manufacturing, and use, has historically presented significant barriers to generic entry [2][3].
What is the difference between Vyvanse and Adderall?
Vyvanse (lisdexamfetamine dimesylate) and Adderall (amphetamine and dextroamphetamine) are both stimulant medications used to treat attention deficit hyperactivity disorder (ADHD) [6]. Vyvanse is a prodrug that is converted to dextroamphetamine in the body, while Adderall contains a mixture of amphetamine salts [5][6]. This difference in formulation means Vyvanse is designed for a longer duration of action and has a lower potential for abuse compared to immediate-release Adderall because it requires enzymatic conversion for activation [5][6].
Can children take generic Vyvanse?
The use of generic medications in children, including those for ADHD, generally follows the same safety and efficacy profiles as their brand-name counterparts, provided they are approved by regulatory bodies. Once generic versions of Vyvanse become available and are approved, they can be prescribed to children according to their doctor's recommendations for ADHD treatment [7].
What are the side effects of Vyvanse?
Common side effects of Vyvanse can include decreased appetite, dry mouth, insomnia, weight loss, irritability, and increased heart rate [8]. More serious side effects may include psychiatric problems such as new or worsened aggression, hallucinations, or manic episodes, and cardiovascular issues like sudden death in individuals with pre-existing heart defects [8].
How much does Vyvanse cost?
The cost of Vyvanse can vary significantly depending on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply can range from several hundred dollars. Generic alternatives, when available, typically offer a lower price point [9].
---
Sources:
[1] https://www.takeda.com/
[2] https://drugpatentwatch.com/blog/vyvanse-patent-cliff-explained/
[3] https://drugpatentwatch.com/
[4] https://www.fiercepharma.com/pharma/viatris-challenges-pfizer-us-patent-vyvanse-as-patent-cliff-looms
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570416/
[6] https://www.additudemag.com/adhd-medication-stimulants-vyvanse-adderall-ritalin/
[7] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients/frequently-asked-questions-about-generic-drugs
[8] https://www.webmd.com/drugs/2/drug-76532/vyvanse-oral/details
[9] https://www.goodrx.com/vyvanse